Literature DB >> 10699329

Purification and characterization of Streptococcus pneumoniae palmitoylated pneumococcal surface adhesin A expressed in Escherichia coli.

B K De1, J S Sampson, E W Ades, R C Huebner, D L Jue, S E Johnson, M Espina, A R Stinson, D E Briles, G M Carlone.   

Abstract

All Streptococcus pneumoniae isolates tested to date express a species-common lipoprotein designated as pneumococcal surface adhesin A (PsaA). This protein is cell-associated, hydrophobic, immunogenic, and genetically conserved. It is currently under investigation as a potential component in third-generation pneumococcal vaccine formulations. To overcome the problem of low-level expression of native hydrophobic PsaA in S. pneumoniae, and also of the recombinant PsaA (rPsaA) in Escherichia coli, we generated a stable E. coli construct expressing functional palmitoylated rPsaA ( approximately 10 mg/l of fermentation culture) using Borrelia burgdorferi outer surface protein A (OspA, a hydrophobic lipoprotein) signal peptide. By Western blot analysis, the chimeric rPsaA ( approximately 34 kDa) was detected in the cell lysate using anti-PsaA antibodies. It was partially purified by extracting the cell pellet with PBS/Triton X(R)-114 buffers, followed by anion exchange filter chromatography. A trypsin digestion profile of rPsaA closely resembled that of the native protein, as revealed by SDS-PAGE/silver staining. Lipidation of rPsaA was confirmed by labeling recombinant E. coli cells with [(3)H] palmitic acid and analyzing the labeled E. coli cells by Western blotting coupled with autoradiography. Further, analysis of purified rPsaA by mass spectrometry (MALDI-TOF) revealed a heterogenous spectrum with a major peak (M+H)(+1) of mass 33,384 Da (theoretical mass of palmitoylated rPsaA=33,361 Da). Purified rPsaA was immunogenic in CBA/NCAHN-XID female mice following intranasal immunization with or without adjuvant, as determined by measurement of anti-PsaA serum IgG levels. These anti-PsaA antibodies reacted with both native and rPsaA polypeptides. Our data strongly suggest that E. coli-expressed rPsaA is palmitoylated and closely resembles the native protein in structure and immunogenicity. It was also observed to elicit measurable protection against nasopharyngeal carriage with S. pneumoniae.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10699329     DOI: 10.1016/s0264-410x(99)00481-8

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  15 in total

1.  Inhibition of pneumococcal adherence to human nasopharyngeal epithelial cells by anti-PsaA antibodies.

Authors:  Sandra Romero-Steiner; Tamar Pilishvili; Jacquelyn S Sampson; Scott E Johnson; Annie Stinson; George M Carlone; Edwin W Ades
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

2.  Optimization of medium formulation and seed conditions for expression of mature PsaA (pneumococcal surface adhesin A) in Escherichia coli using a sequential experimental design strategy and response surface methodology.

Authors:  Ariane Leites Larentis; Júlia Fabiana Monteiro Quintal Nicolau; Ana Paula Corrêa Argondizzo; Ricardo Galler; Maria Isabel Rodrigues; Marco Alberto Medeiros
Journal:  J Ind Microbiol Biotechnol       Date:  2012-02-25       Impact factor: 3.346

Review 3.  Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review.

Authors:  S Sethi; T F Murphy
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

4.  Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae.

Authors:  Dennis O Gor; Xuedong Ding; David E Briles; Michael R Jacobs; Neil S Greenspan
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

5.  Lipoprotein PsaA in virulence of Streptococcus pneumoniae: surface accessibility and role in protection from superoxide.

Authors:  Jason W Johnston; Lisa E Myers; Martina M Ochs; William H Benjamin; David E Briles; Susan K Hollingshead
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

6.  Enhanced immunogenicity of pneumococcal surface adhesin A by genetic fusion to cytokines and evaluation of protective immunity in mice.

Authors:  Dennis O Gor; Xuedong Ding; Qing Li; John R Schreiber; Michael Dubinsky; Neil S Greenspan
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

7.  Immune response to Lactobacillus plantarum expressing Borrelia burgdorferi OspA is modulated by the lipid modification of the antigen.

Authors:  Beatriz del Rio; Jos F M L Seegers; Maria Gomes-Solecki
Journal:  PLoS One       Date:  2010-06-18       Impact factor: 3.240

8.  The Mycobacterium tuberculosis recombinant 27-kilodalton lipoprotein induces a strong Th1-type immune response deleterious to protection.

Authors:  Avi-Hai Hovav; Jacob Mullerad; Liuba Davidovitch; Yolanta Fishman; Fabiana Bigi; Angel Cataldi; Herve Bercovier
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

9.  Role of Pht proteins in attachment of Streptococcus pneumoniae to respiratory epithelial cells.

Authors:  Anna Kallio; Kirsi Sepponen; Philippe Hermand; Philippe Denoël; Fabrice Godfroid; Merit Melin
Journal:  Infect Immun       Date:  2014-02-03       Impact factor: 3.441

10.  Molecular characterization and subcellular localization of macrophage infectivity potentiator, a Chlamydia trachomatis lipoprotein.

Authors:  Laurence Neff; Sawsan Daher; Patrick Muzzin; Ursula Spenato; Fazil Gülaçar; Cem Gabay; Sylvette Bas
Journal:  J Bacteriol       Date:  2007-04-20       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.